Ross Moat Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Ross Moat is CHIEF COMMERCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 21,736 shares of KNSA, which is worth approximately $458,412. The most recent transaction as insider was on Jul 15, 2022, when has been sold 360 shares (Class A Common Share) at a price of $9.56 per share, resulting in proceeds of $3,442. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.7K

18.19% 3M change

50.74% 12M change

Total Value Held $458,412

Ross Moat Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 15 2022	BUY Grant, award, or other acquisition	$3,442 $9.56 p/Share	360 Added 4.45%	7,732 Class A Common Share
Mar 21 2022	SELL Payment of exercise price or tax liability	$13,615 $10.98 p/Share	1,240 Reduced 14.4%	7,372 Class A Common Share
Mar 21 2022	BUY Exercise of conversion of derivative security	-	2,270 Added 20.86%	8,612 Class A Common Share
Mar 16 2022	SELL Payment of exercise price or tax liability	$5,511 $10.13 p/Share	544 Reduced 7.9%	6,342 Class A Common Share
Mar 16 2022	BUY Exercise of conversion of derivative security	-	995 Added 12.63%	6,886 Class A Common Share
Jan 15 2022	BUY Grant, award, or other acquisition	$14,888 $9.63 p/Share	1,546 Added 20.79%	5,891 Class A Common Share
Jul 15 2021	BUY Grant, award, or other acquisition	$11,065 $11.49 p/Share	963 Added 18.14%	4,345 Class A Common Share

Ross Moat

CHIEF COMMERCIAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account